The current valuation score of Armata Pharmaceuticals Inc is 8.44, ranking 133 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.76, which is -100.00% below the recent high of 0.00 and -28383.37% above the recent low of -215.85.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.